C24.9 - Malignant neoplasm of biliary tract, unspecified
| ICD-10: | C24.9 |
| Short Description: | Malignant neoplasm of biliary tract, unspecified |
| Long Description: | Malignant neoplasm of biliary tract, unspecified |
| Status: | Valid for Submission |
| Version: | ICD-10-CM 2023 |
| Code Classification: |
C24.9 is a billable ICD-10 code used to specify a medical diagnosis of malignant neoplasm of biliary tract, unspecified. The code is valid during the fiscal year 2023 from October 01, 2022 through September 30, 2023 for the submission of HIPAA-covered transactions.
The following anatomical sites found in the Table of Neoplasms reference this diagnosis code given the correct histological behavior: Neoplasm, neoplastic bile or biliary (tract) or Neoplasm, neoplastic hepatobiliary .
Unspecified diagnosis codes like C24.9 are acceptable when clinical information is unknown or not available about a particular condition. Although a more specific code is preferable, unspecified codes should be used when such codes most accurately reflect what is known about a patient's condition. Specific diagnosis codes should not be used if not supported by the patient's medical record.
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Carcinoma liver and/or biliary system
- Malignant polyp of biliary tract
- Malignant tumor of biliary tract
- Primary adenocarcinoma of biliary tract
- Primary malignant neoplasm of biliary tract
- Primary mucinous cystic neoplasm with associated invasive carcinoma of biliary tract
- T1: Tumor limited to ampulla of Vater or sphincter of Oddi
Convert to ICD-9 Code
| Source ICD-10 Code | Target ICD-9 Code | |
|---|---|---|
| C24.9 | 156.9 - Malig neo biliary NOS |
Table of Neoplasms
This code is referenced in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.
Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.
| Neoplasm, neoplastic | Malignant Primary |
Malignant Secondary |
CaInSitu | Benign | Uncertain Behavior |
Unspecified Behavior |
|---|---|---|---|---|---|---|
| »Neoplasm, neoplastic »bile or biliary (tract) | C24.9 | C78.89 | D01.5 | D13.5 | D37.6 | D49.0 |
| »Neoplasm, neoplastic »hepatobiliary | C24.9 | C78.89 | D01.5 | D13.5 | D37.6 | D49.0 |
Patient Education
Bile Duct Cancer
Your liver makes a digestive juice called bile. Your gallbladder stores it between meals. When you eat, your gallbladder pushes the bile into tubes called bile ducts. They carry the bile to your small intestine. The bile helps break down fat. It also helps the liver get rid of toxins and wastes.
Bile duct cancer is rare. It can happen in the parts of the bile ducts that are outside or inside the liver. Cancer of the bile duct outside of the liver is much more common. Risk factors include having inflammation of the bile duct, ulcerative colitis, and some liver diseases.
Symptoms can include:
- Jaundice
- Itchy skin
- Fever
- Abdominal pain
Tests to diagnose bile duct cancer may include a physical exam, imaging tests of the liver and bile ducts, blood tests, and a biopsy.
Treatments include surgery, radiation therapy, and chemotherapy.
NIH: National Cancer Institute
[Learn More in MedlinePlus]
What is Bile Duct Cancer (Cholangiocarcinoma)?
Learn about bile duct cancer (cholangiocarcinoma) risk factors, symptoms, tests to diagnose, factors affecting prognosis, staging, and treatment.[Learn More in MedlinePlus]
Code History
- FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
- FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)